CERo Therapeutics Holdings, Inc. (CERO) OTC

0.09

-0.01395(-13.41%)

Updated at December 19 02:03PM

Currency In USD

Valuation

Market Cap14.5M
Enterprise Value12.74M
P/E Ratio-0.01
PEG Ratio-0
Price/Sales Ratio0.1
Price/Book Ratio-0.03
Enterprise/Revenue-0.84
Enterprise/EBITDA0.08

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-17.87
Operating Margin-13.1

Management Effectiveness

Return On Assets-5.31
Return On Equity9.9

Income Statement

Revenue0
Revenue/Share0.92
Gross Profit-1.16M
EBITDA-6.57M
Net Income-7.73M
Diluted EPS-6.87

Balance Sheet

Total Cash2.02M
Total Cash/Share1.6
Total Debt931,023
Total Debt/Equity-0.2
Current Ratio0.3
Book Value Per Share-3.59

Price History

52-Week Change-99.91
52-Week High206
52-Week Low0.05
Moving Average 50 Days0.8
Moving Average 200 Days8.43

Statistics

Average Volume2.56M
Shares Outstanding1.21M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 13, 2025